相关实验视频

Updated: Jun 17, 2026

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis ALS

Published on: February 21, 2011

液体生物标志物用于肌缩侧面硬化症:一个审查

Katherine E Irwin^1,2, Udit Sheth^3,4, Philip C Wong^5,6

¹Department of Pathology, Johns Hopkins Medicine, Baltimore, MD, 21205, USA.

Molecular neurodegeneration

|January 24, 2024

概括

液体生物标志物对于诊断和治疗肌缩侧面硬化症 (ALS) 是一种致命的神经退行性疾病至关重要. 研究正在推进,为ALS患者找到更好的诊断和预后标志物.

科学领域:

神经科学是一个神经科学.
生物标志物研究生物标志物研究
临床试验临床试验

背景情况:

肌缩侧面硬化 (ALS) 是一种致命的神经退行性疾病,影响运动神经元.
目前对ALS的治疗缓慢下降,但没有提供治愈,突出需要更好的管理策略.
诊断后预期寿命很短,这凸显了改善诊断和治疗方法的紧迫性.

研究的目的:

审查确定ALS流体生物标志物的进展情况.
讨论诊断,预后,易感性和治疗反应的生物标志物.
为了促进更快的ALS诊断,更好的预后预测,以及改善临床试验设计和解释.

主要方法:

过去二十年来对ALS生物标志物研究的综合文献综述.
分析已识别的诊断,预后,易感/风险和反应流体生物标志物.
讨论ALS生物标志物发现和开发的新兴策略.

主要成果:

在过去的20多年中,已经确定了几种有前途的ALS液体生物标志物候选者.
该审查巩固了与ALS患者护理相关的生物标志物发现的努力.
目前正在探索生物标志物开发的新策略.

结论:

液体生物标志物对于促进ALS护理和治疗发展至关重要.
对新型生物标志物的持续研究将改善诊断准确性和预后预测.
增强的生物标志物策略对于优化临床试验和ALS患者的治疗结果至关重要.

关键词:

肌缩性侧面硬化症 (AMLS) 是一种疾病.大脑脊髓液中的脑脊液.临床试验临床试验是指临床试验的临床试验.流体生物标志物流体生物标志物神经纤维纤维是一种神经纤维.在等离子体中,我们可以得到等离子体.血清的血清是什么意思在TDP-43中使用.

更多相关视频

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets

Use of Capillary Electrophoresis Immunoassay to Search for Potential Biomarkers of Amyotrophic Lateral Sclerosis in Human Platelets

Published on: February 10, 2020

相关概念视频

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...